Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What is going on 1/28/16????
Say what you want but I am adding at those prices for sure !!!!!! And in 6-12 month we can talk about the price of this stock
Going higher soon !!!!!!!!!
Four Economic Predictions for Hemp
Marijuana Trends & ArticlesJan 7, 2016
Those who wish to legalize industrial hemp highlight that the plant has the possibility of generating a ton of revenue for U.S. cultivators, making the best out of this country’s economy and agricultural industry. Although legalizing marijuana is more controversial, the industrial hemp activism is more important for the United States as a whole, especially from an economic standpoint. Now, let’s take a look at four economic predictions by those who have been researching industrial hemp:
Great for farmers
U.S. consumers buy $500 million of hemp products per year. The products, which are brought in from other countries, consist of health and beauty products, clothing, food, as well as sundry environmentally safe consumables. If cultivators in the United States were given the ability to grow industrial hemp, all those dollars would be a part of the American economy rather than to the economies of other countries.
2. More Jobs
Industrial hemp would likely create jobs in an industry where they are heavily needed. Agrarian economies took the largest impact in the recession over the last couple of years, and many regions still have not bounced back from the loss of jobs. If industrial hemp were allowed, there would be a stable agrarian economy in rural areas that would provide jobs for many.
3. Keeping Cash in the U.S.
Hemp is going to be a growing industry for a long time. In 2011, the United States brought it $11.5 million in raw hemp material in order to make goods. This is four times the market value that was brought in just a decade ago. More and more products are being made from raw hemp materials. As a result, hemp imports will become increasingly expensive until we begin to grow our own hemp.
4. Profit
The market outlook for industrial hemp is positive, according to economists from the USDA and various land grant universities. They have been studying the possibilities for hemp in various states and discovered that outlook is positive everywhere. Of course, there would be ups and downs, but overall, hemp is an evidently profitable plant.
FacebookTwitterGoogle+Share
TAGSBEST MARIJUANA STOCKSCANNABIS STOCK NEWSCANNABIS STOCKSCROPCULTIVATIONHEMPINDUSTRIAL HEMPMARIJUANA INDUSTRY NEWSMARIJUANA STOCKSMARIJUANA STOCKS NEWSNEWSPOT STOCKSU.S.USDAWEED STOCKS
Consolidation at .085--.03 level and we should go higher .
NY going legal on medical marijuana on Thursday.
COO purchased 2,000,000 shares good news !!!!!!!!
Medbox Completes Purchase of San Diego Retail Property For Medical Marijuana Dispensary
-- Build-out to Begin Immediately, with Opening Scheduled for May --
Los Angeles, California (FSCwire) - Medbox, Inc. (OTCQB: MDBX), a provider of specialized services to the cannabis sector, including operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved, today announced that it has completed the purchase of a two-story, 7,500 square-foot retail property in San Diego, which will house a medical marijuana dispensary, scheduled to open in May of this year.
Medbox will assist with the build-out of the property, which is located at 3385 Sunrise Street, just east of downtown, and will consult with the dispensary operator, Rise Industries, Inc., on compliance, training and related matters. Medbox will be paid a fee for its services, expected to approximate half of the dispensary’s annual profits. The purchase price of the building was $937,369.
The City of San Diego awarded Medbox a Conditional Use Permit (CUP) in September 2015, granting the company a license for the operation of the dispensary. The CUP is one of eleven to be awarded thus far.
Also as part of the Medbox CUP, Rise Industries is serving as operator of Sunrise Patient Group, a medical marijuana home delivery service, for Medbox’s client, Alternative Health Cooperative, Inc. The delivery service opened in December and already has attracted an active clientele.
“We are pleased to begin the build-out of what we believe will be a highly successful medical marijuana dispensary, providing patients with safe access to high quality products,” said Jeff Goh, President and interim Chief Executive Officer. “San Diego is a vibrant market, and our award of the CUP demonstrates both our professionalism and leadership role in the cannabis sector.”
About Medbox, Inc.
Medbox, Inc., a leader in the rapidly emerging cannabis sector, provides specialized services to operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved. Through trusted clients and affiliates, the company promotes efficient, consistent, high quality products that are priced right, readily available and safely packaged. For more information about the company or to explore partnership, please visit www.medbox.com.
Forward-Looking Statements
Certain statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, the dispensary opening for business in May, are based on current beliefs and expectations and are inherently subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the company’s control. In addition, certain forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, regulatory developments in the industry, as well as political and economic conditions present within the industry. For a more detailed description of the risk factors associated with the company, please refer to the company’s latest Annual Report on Form 10-K, and in particular, the section entitled “Risk Factors” therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law.
For more information, contact:
Janet Simmons
PondelWilkinson Inc.
310-279-5980
pwinvestor@pondel.com
Happy New Year!!!!!!!!
Medbox will be huge in 2016
Good news !!!!!!!!
The agreement represents a positive step in our financial structure that lowers costs to the company and provides a lock-up period that we believe will reduce selling pressure on our securities,” said Jeff Goh, President and interim Chief Executive Officer. “Equally important, it signals added confidence that our lenders have in Medbox, as the company continues to make solid operational progress and looks forward to profitable revenue growth in 2016 and beyond.”
Unfortunately 88k short shares is not enough of shares for short squeeze . The stock will go up anyway soon !
The amount of shares tradet this week is insane look at today short day but we did over 5m on the buy side . We are going higher starting Janury take a chance and add to your position now while people selling for tax purpose !
News!!!!!!!!!!
Equities.com interview:
Jeff Goh, CEO of Medbox: The Cannabis Industry Has Come a Long Way
Daniel Banas | Thursday, 17 December 2015 17:31 (EST)
https://res.cloudinary.com/equities-com/image/upload/v1/u/389bc7bb1e1c2a5e7e147703232a88f6/ch3tpnsersegadq1cyka
As the President and CEO of Medbox (OTCQB:MDBX), a provider of consulting services to operators of dispensaries, cultivation centers, manufacturers, and research facilities, Jeff Goh is working on the front lines of the cannabis industry. Goh's position within this rapidly growing industry gives him and insider's view on the nation's steady march towards broader legalization. Equities.com got a chance to talk with Mr. Goh about where the industry, and the country, is headed.
EQ: The culture around cannabis, particularly in legalized states, has become very different from what’s often portrayed in the mainstream, and the lifestyle trends are more modern than many people realize. How far has this industry come in past few years?
The cannabis industry has come a long way in the past few years, but I believe the changes we have seen are just the tip of the iceberg. Particularly in the medical community, skepticism from physicians is shifting to acceptance, as more patients experience real benefits for pain management. As more states legalize marijuana for medical and recreational use, general consumer acceptance also is occurring. This year a Gallup poll had 58% of Americans in favor of legalization of cannabis.
All of these factors we believe will serve to professionalize the sector and mandate product consistency and quality.
EQ: The cannabis industry is very much a growth market with no dominant players. What will it take to become a household name as this industry continues to mature?
As in any emerging industry with high potential, there are many entrants at the moment, some in for the long-term, others to make short term money. Over time—and this is starting to happen already—we will be seeing consolidation. There are many barriers to entry, like the increased difficulty in obtaining licenses and the increasing costs of compliance, for example. The growth opportunities for cannabis are so strong. There will always be entrepreneurial, smaller operators, big players with branded offerings, and scale will eventually emerge…first on the medical side, which is now establishing itself across the country, and soon thereafter on the recreational side.
EQ: One of the key concerns around wider use of cannabis is consumer safety, proper consumption levels, transparency, etc. What steps is the industry taking to address those concerns?
Safety, proper consumption levels, and a host of other concerns—including product quality and consistency—are major initiatives that Medbox and others are addressing. A combination of increasing public information and the emergence of professionally-run companies will be of enormous benefit in assuring that those concerns are addressed. The consumer is getting smarter as well, and legalization with associated regulation will also play a major role.
EQ: The most significant catalyst for this industry is the expansion of legalization state-to-state. Do you feel momentum is picking up with each new state legalizing cannabis?
There is no question that momentum is growing...rapidly. Twenty-three states have approved marijuana for medical use, and voters in four states plus the District of Columbia have granted approval for recreational use. More initiatives are being added to ballots across the country, so there is no question that the sector is growing. I especially think if California, Nevada, and Arizona go recreational, we could reach a tipping point where the federal government may want to accelerate their efforts to get involved.
EQ: On the flipside, arguably the toughest challenge is legalization on the federal level. How has that impacted the industry’s growth and the ability to meet market demand?
As I said before, I believe it is only a matter of time before approval is granted at the federal level. Canada is a prime example, with the new administration stating that national approval is imminent. The benefits on the medical side are clear: nearly half of the states already have granted approval and legalization is proving to create quality and eliminate the criminal element. It is somewhat ironic that the District of Columbia has approved marijuana for recreational use, so we continue to believe federal approval will not be too far off.
EQ: You have extensive experience in fields like the food industry and education. How does the cannabis sector differ from other markets that you’ve observed throughout your experience?
In a way, my prior experience suits me well for the cannabis sector. Many of the same principles apply, namely, the cultivation aspects, the adherence to consistency and the assurance of quality end products. So while our industry is still in its infancy from a big business perspective, applying professional disciplines to an agricultural product—be it the potatoes that we grew and processed at Frito Lay (PEP)—from seed to sale—this is definitely something I have experience in.
You can read more from our special program The Future of Cannabis here. To find out why Equities.com and Viridian Capital Advisors launched this program, be sure to read What is The Future of Cannabis?? This program was made possible by the support of our sponsors.Click here for a full list of our sponsors.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
Another sign of manipulation they did this on purpose so all the market orders will kick in and they picked up around 3 million shares under three cents . That just shows me one more sign to buy and hold
#Marijuana Growers Look For Self Containment: Is This Where Investors Should Be Looking for the Next Boom?
Marijuana Sector NewsDec 18, 2015
If you take a glance at the markets for marijuana and related industries, prices have seen a rebound where many “played out” stocks have received a breath of fresh air…along with their long-term investors. Many are even calling this the rebirth of pot stocks as a whole and for new companies coming into the space, this along with tighter regulations to protect investors could be significant catalysts for the market to continue to grow, literally.
But the fact of the matter still remains that without the actual plant itself, users, retailers, and alchemists would have nothing. Today’s economic boom within legal marijuana has ignited a firestorm of interest from some of the most unlikely proponents of marijuana’s success. Biologists and engineers have experimented with digital sensors, lighting arrays, software programs and ventilators to self-contained systems with the lowest energy costs and highest crop yields.
Being that marijuana needs a precise balance of light, moisture and water to thrive it is a very finicky crop but new technologies outside of the typical outdoor grow or even traditional green house grow have begun to come about. As the U.S. and more countries ease up their policies on both medical and recreational marijuana, the race is on by companies working to become the industry leaders in data-mining software, lamps with efficiency accessories and adequate irrigation systems.
These tools will ultimately benefit more than marijuana growers alone. We’re talking things like industrial food producers and even the hemp growers could adapt the same technologies to cut energy costs and boost their yields. Operators of large buildings could use the systems to lower their electricity use as well. By compartmentalizing these units, growers have been able to streamline operations, magnify growing conditions and yield more consistent crops multiple times throughout the year.
“Cannabis is spurring on an ag-tech revolution. This is a boom born entirely out of ending repressive laws. The market is already there, it’s just moving from the shadows into the light. That’s why you’re seeing this incredible growth and why so many people see it as a once-in-a-lifetime [business] opportunity.”
-Troy Dayton, CEO of ArcView Group.
Technology advancements in the marijuana industry focus mainly on interior cooling, air circulation, and lighting, which together take up about 70% of the overall cost to actually grow a single gram of weed; this is according to some projections. Using water more efficiently, take up less stress on the electrical grid while providing greater yields is a very realistic advantage of these more controlled “grow box” style units. Others are even being designed to automate the real-time response to changes in variables like moisture, sunlight and temperature, in order for the cannabis to grow in an optimal environment. Technologies also collect a wealth of data, which gives growers an upper hand when it comes to adjusting their growing environments to find the best conditions for multiple varieties.
Timing may not be any better than right now to start digging into this industry. The space is drawing interest from the mainstream believe it or not. A subsidiary of Scotts Miracle-Gro Co., Hawthorne Gardening Co. in April, purchased General Hydroponics Inc. and Bio-Organic Solutions Inc. They make liquid nutrients for indoor marijuana cultivation and this is just one example of the types of investments these “blue chip” companies are making in order to get a foot in the door when it comes to the new kinds of growing environments being created.
No longer are harvests limited to a few times a year. These grow boxes can produce several FULL harvests per year and when it comes to out put meeting demand this is one of the most important aspects of a successful grow. Furthermore, with the industry attracting a new breed of entrepreneurs who may have never even touched marijuana before, grow box manufacturers also need to consider ease of use; Can it be “plug and play”?
U.S. cannabis sales alone reached $2.7 billion in 2014, a $1.1 billion gain over 2013. Now think about this for a moment, Colorado marijuana sales alone for the first 8 months of 2015 totaled nearly $700M (almost 30% of the total U.S. sales for 2014 and remember…that’s just Colorado). The market continues to grow and so has the increasing demand for a consistent, quality product that as of recent has been found to be a byproduct of indoor grow box cultivation methods. It would stand to reason that just like the picks and shovels of the gold rush, these lights, water units, and especially the cultivation boxes will become an industry all their own.
Bank of America Releases Report on the Marijuana Industry
Political Marijuana NewsDec 18, 2015
Early on in December, Bank of America Merrill Lynch released a research report projecting the future of the cannabis industry. This is one of the first research reports from a major financial institution, so a milestone has been reached in one of the fastest-growing industries that is seeking more recognition and the profits that come along with that recognition. However, the report makes it evident that cannabis still has a long way to go till it is considered a normal industry.
At the moment, 23 states have legalized some form of cannabis, most of which are medical. Four states and Washington, D.C., have legalized marijuana for recreational use. Also, next election day, California and, at least, five other states are likely going to hold a vote on cannabis legalization. In 2014, legal marijuana was the quickest growing sector in the United States, grossing $2.7 billion. According to the report, this year will not be different and by 2020, the industry can generate up to $35 billion. However, legal marijuana is still a minor American industry since there are just a few growers, manufacturers, and sellers throughout the country.
The report is called “Medical Cannabis has high POTential: A joint biotech and tools Primer” and actually is of benefit to marijuana because it approaching the crop seriously. The focus of the article is on the medical side, including sections of drugs derived from cannabis to treat a wide variety of ailments, including schizophrenia, type II diabetes, post-traumatic stress disorders and even types of cancer. Marijuana advocates believe that crop has many more uses that the country just has not seen yet. The report is sure to mention this and attest to the possibility.
“The good news out of all this is it just opens [Wall Street’s] eyes to an investment scene that they may not even appreciate yet,” stated analyst Alan Brochstein, whose businesses 420 Investor and New Cannabis Ventures focus on the marijuana industry and finance. However, he states that the report lacks “actionable information” that would sway a potential investor.
Looks like bounce in early trading already bid 0.0165
Let's take this higher who is with me ?
Big up day tomorrow!!!!!
Are we starting to move higher ?
80 million shares tradet in last 6 days. Looks like a very strong support at .02 to me . I really don't see this going much lower especially with news that will be coming in about hemp growing in the Pueblo property . We should go up next week !
I am buying more at this levels way oversold !!!!!
Merrill Lynch, the investment branch of Bank of America and a powerhouse in the areas of financial and investment advising, has circulated a detailed overview of the marijuana industry.
The report is close to 50 pages long and has intensive research into a variety of different financial metrics and business predictions having to do with the marijuana industry.
However it has not yet been published publicly, Chris Goldstein of Philly420 has identified a leaked version of the document.
In reference to Goldstein, the document goes over a variety of marijuana-related products, markets, and fields. It also addresses the current legal status of marijuana, since this plays an obviously central role in the overall profitability of marijuana as a legal product. Eventually, the report settles into a long exploration of the investment possibilities of what Merrill Lynch advisors termed the “Life Science Tools” sector of the marijuana industry.
This sector has to do with the lab testing required by states where cannabis is allowed legally.
These test screen for a multiple different safety factors and marijuana must initially be analyzed and approved by these labs prior to being sold in marijuana shops. As worries over the dangers of pesticides have become a trending topic this year, many states have started creating stricter laws to regulate the types of pesticides that can be used on marijuana crops.
Complying with these new and stricter regulations is likely to become an increasingly important—and increasingly costly—factor of the overall marijuana industry. For Merrill Lynch, this stands for a potentially profitable place for cannabis investors to focus their money, which is why their analysts concluded that the company is “bullish on the cannabis testing market.”
The report also pointed out a number of “major players” involved in manufacturing the equipment need to conduct cannabis lab tests. These include: “Agilent Technologies, a $4 billion dollar company based in Santa Clara, California; Waters Corporation a $2 billion dollar company based in Massachusetts; and Thermo Fisher Scientific a $17 billion dollar company that keeps two offices in Philadelphia.”
The report also “estimates that the market for this equipment could grow to between $50 million and $100 million by 2020.”
The burgeoning marijuana industry has already gained the attention of a wide range of investors with deep pockets. A report like this, coming from an investment powerhouse like Merrill Lynch, could be a sign of even bigger business opportunities in the future—especially as marijuana becomes legal in more states throughout the united states.
This is what I think if the company was thinking that they are going out of business they would never settle the class action lawsuit right now they would wait ! The reason they settled quickly is because they know that next three months they would get a good size of revenue from growing and if they would wait to settle they would need to pay much more money for the settlement . People that believe in Colorado area told me that green houses that are on the property are up and running we should get $$$$$ soon !!!!!!! Strong buy !!!!!!!!!!!!
Here we go ready for take off !!!!!!
We will run at the end of the day today !
Green houses are up and running huge gap up this week! Vincent out of the picture is a good thing people that bought his shares will hold it for a long term . Good luck to all !
Vincent sold his whole position of 8m shares last week and that's why we went down not because people are selling and not because note holders are selling . Note holders will not sell below .255 they don't want to loose money . We should go up next week !
Vinny sold all of his shares that's why we went down for 2 days . Anybody looking for a bounce next week ?
Looks like they not selling below .025 that's what price of those notes are
Oversold !!! Strong buy
News!!!!!!!
Medbox to Provide Advisory Services To Manufacturer of Branded Cannabis-based Medicinal Tablets
Irvine, CA (FSCwire) - Medbox, Inc. (OTCQB: MDBX), a provider of specialized services to the cannabis sector, including operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved, today announced it will provide manufacturing advisory services and oversight for PrimaCan, a manufacturer of branded cannabis-based medicinal tablets sold to medical marijuana dispensaries, principally in Southern California.
As part of its services, Medbox will lease a facility in Orange County, California, to house the manufacturing operations, as PrimaCan expands production and distribution of its branded edible products. PrimaCan was founded in 2013 and currently manufactures six products, sold under prescription, for pain management and other medical indications.
“We are pleased to help PrimaCan enhance its industry presence and provide its quality branded products to an increasing number of patients,” said Goh. “At the same time, we view our work with PrimaCan as providing opportunity for Medbox to achieve another viable, ongoing stream of revenues.”
Nov 21 2015!
Go to OTC website and look its report from S and P capital .
Look at Aug 24th chart it looks like same pattern
All signals big bounce this week
RSI 26 , WM %r 96 very oversold .
I think it should bounce the same way it did in AUG 24
14DMA is at .05c 1st resistance than 50DMA and 100DMA been coming down and now at .08c second resistance . I really think if some news about greenhouses and cultivation is starting we can jump up soon .
I been accumulating shares every day last week . Anybody else doing the same ?
Investors are accumulating shares !!!! We are way oversold and bounce is coming next week !
On November 16, 2015, the Company and the Investor entered into a second supplemental agreement (the "Second Supplemental Agreement"), providing for the Third Closing be amended to occur in five tranches, with four tranches of $125,000 of Debentures to close on each of November 16, 23, 30 and December 7 and a fifth closing of $200,000 of Debentures to close within two (2) days of the Effective Date.
We will start going higher next week that's why they kept price down .
I am puting real money trust me !!!!
Good news is coming next week !
I don't care if it goes to .03 or .01 I will continue to add to my position and next year will be nice for me .
Go to ot markets.com than when you put MDBX click on research reports and you will see report from S and P capital that was posted 3 days ago
I'm loading more at those levels also !!!!!!!